Tarsus Pharmaceuticals, Inc. (TARS)
80.28
+3.39
(+4.41%)
USD |
NASDAQ |
Nov 13, 16:00
80.40
+0.12
(+0.15%)
After-Hours: 19:59
Tarsus Pharmaceuticals EPS Diluted (Quarterly) : -14.40 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -14.40 |
| June 30, 2026 | -0.4275 |
| March 31, 2026 | -0.1622 |
| December 31, 2025 | -0.1957 |
| September 30, 2025 | -0.2954 |
| June 30, 2025 | -0.4802 |
| March 31, 2025 | -0.6384 |
| December 31, 2024 | -0.5994 |
| September 30, 2024 | -0.6102 |
| June 30, 2024 | -0.8802 |
| March 31, 2024 | -1.012 |
| December 31, 2023 | -1.312 |
| September 30, 2023 | -1.278 |
| June 30, 2023 | -1.172 |
| March 31, 2023 | -0.8757 |
| Date | Value |
|---|---|
| December 31, 2022 | -0.5088 |
| September 30, 2022 | -0.8443 |
| June 30, 2022 | -0.236 |
| March 31, 2022 | -0.9772 |
| December 31, 2021 | -0.7175 |
| September 30, 2021 | -0.7605 |
| June 30, 2021 | 0.2869 |
| March 31, 2021 | 0.4716 |
| December 31, 2020 | -0.5642 |
| September 30, 2020 | -0.4989 |
| June 30, 2020 | -0.1599 |
| March 31, 2020 | -0.0963 |
| December 31, 2019 | -0.0695 |
| September 30, 2019 | -0.0335 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Bristol Myers Squibb Co. | 1.053 |
| Amneal Pharmaceuticals, Inc. | -0.0646 |
| Harmony Biosciences Holdings, Inc. | 0.8076 |
| ANI Pharmaceuticals, Inc. | 1.510 |
| Corcept Therapeutics, Inc. | 1.010 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -668.33M |
| Revenue (Quarterly) | 194.57M |
| Total Expenses (Quarterly) | 862.90M |
| Enterprise Value | 3.737B |
| Gross Profit Margin (Quarterly) | 92.86% |
| Profit Margin (Quarterly) | -343.5% |
| Earnings Yield | -18.91% |
| Normalized Earnings Yield | -7.068 |